School of Medicine, V. N. Karazin Kharkiv National University
Department of Human Anatomy and Physiology
University class presentation on the topic "Features of cardiovascular system activity in various climatic & geographical conditions" for the discipline Anatomical & Physiological Aspects of Cardiovascular System by SANSKAR VIRMANI
Presentation is free to use for non-monetary purposes if the author (i.e., me) is properly cited and given due credits.
LinkedIn Profile: bit.ly/SanskarV_LinkedIn
Hypertension is a silent, invisible killer that rarely causes symptoms. Increasing public awareness is key, as is access .Raised blood pressure is a warning sign that significant lifestyle changes are urgently needed. People need to know why raised blood pressure is dangerous, and how to take steps to control it.
The Future of Cardiology (2018 – 2030): Advanced Treatments to Combat the Global Advance of Cardiovascular Diseases. I presented this at Conference Series Cardiology Conference 2017 in Philadelphia, Pennsylvania on 09/01/2017. I first look the the number of people globally affected by cardiovascular diseases. Then I look at the cumulative "lost productivity" globally as a result of people suffering from cardiovascular diseases. Following that, I look at the total costs of treating cardiovascular diseases globally. Then I present the reasons why cardiovascular diseases are rising so rapidly throughout the world - lifestyle/clinical. Then I look at the rates of smoking throughout the world; one of the main culprits of cardiovascular diseases (CVDs). The next slides look at the "Gold Standard" of care for coronary artery diseases (CAD), congestive heart failure (CHF), and aortic valve disease. I also present what is driving industry consolidation and associated major transactions. I then provide some perspective on the future of interventional cardiology. And finally, I provide some insight into "evolving technologies" for cardiovascular care and interventional cardiovascular care. It was a lengthy presentation, but I feel, all critical. This is a very complex field. It takes at least 12 continuous years of education and training to become an interventional or non-interventional cardiologist (4 years pre-med, 3 years medical school, 3 years medical residency, 2 years fellowship (where a cardiologist selects and trains on their cardiovascular specialties)). Some authorities are even calling for post-fellowship training for procedures like transcatheter aortic valve implantation (TAVI) and pacemaker/ICD implantation.
Review ArticlePotential role of sugar (fructose) in the ep.docxronak56
Review Article
Potential role of sugar (fructose) in the epidemic of hypertension,
obesity and the metabolic syndrome, diabetes, kidney disease, and
cardiovascular disease1�3
Richard J Johnson, Mark S Segal, Yuri Sautin, Takahiko Nakagawa, Daniel I Feig, Duk-Hee Kang, Michael S Gersch,
Steven Benner, and Laura G Sánchez-Lozada
ABSTRACT
Currently, we are experiencing an epidemic of cardiorenal disease
characterized by increasing rates of obesity, hypertension, the met-
abolic syndrome, type 2 diabetes, and kidney disease. Whereas ex-
cessive caloric intake and physical inactivity are likely important
factors driving the obesity epidemic, it is important to consider
additional mechanisms. We revisit an old hypothesis that sugar,
particularly excessive fructose intake, has a critical role in the epi-
demic of cardiorenal disease. We also present evidence that the
unique ability of fructose to induce an increase in uric acid may be a
major mechanism by which fructose can cause cardiorenal disease.
Finally, we suggest that high intakes of fructose in African Ameri-
cans may explain their greater predisposition to develop cardiorenal
disease, and we provide a list of testable predictions to evaluate this
hypothesis. Am J Clin Nutr 2007;86:899 –906.
KEY WORDS Fructose, uric acid, sugar, arteriosclerosis, en-
dothelial dysfunction, hypertension, obesity, chronic kidney dis-
ease, metabolic syndrome
INTRODUCTION
Despite our best efforts, the epidemic of cardiorenal disease
continues to increase at an alarming rate. Obesity affects one-
third of adults and one-sixth of children in the United States and
continues to increase; although dietary interventions are often
initially successful, they often fail over time because of attrition
(1). Likewise, hypertension affects nearly one-third of the pop-
ulation, but despite the presence of effective antihypertensive
agents, nearly two-thirds of these patients remain either un-
treated or are treated ineffectively (2). Furthermore, even if the
hypertension is controlled, these subjects continue to have in-
creased cardiovascular mortality (3). Diabetes, a complication of
obesity, now affects 7% of our population, with approximately
one-third doomed to develop various complications such as ret-
inopathy or nephropathy (4). Kidney disease also continues to
increase at a deplorable rate, a consequence of the increasing
frequency of hypertension and diabetes (5). Today, nearly 20
million Americans have stage 1 kidney disease or greater (de-
fined as the presence of microalbuminuria or a glomerular fil-
tration rate �90 mL�min�1�1.73 m�2; 6), and, although treat-
ments such as angiotensin-converting enzyme inhibitors are
beneficial, they act primarily to delay the progression to renal
failure as opposed to halting the process (7).
It is our opinion that the potential mechanisms underlying the
epidemic should be carefully reappraised. On the basis of both
the experimental studies performed in our laboratorie ...
http://www.thinkred.co.za/get-involved/events | Thousands of people around the globe are affected by at least one type of Cardiovascular Disease (CVD) every day. This only emphasises the importance of heart health in this day and age. Learn what CVD is about the impact that it has had on people over the years. With simple diet and lifestyle changes many diagnosed individuals can overcome this threat.
Liz Rolfe's presentation Health Inequalities within an Ageing Population (SWO Seminar, Gloucestershire Local Intelligence Network).
Thursday 5th November 2009
Assessment of the Prevalence of Some Cardiovascular Risk Factors among the O...Scientific Review SR
The prevalence of some cardiovascular risk factors among the Ogonis and Ikwerres in Rivers State,
Nigeria was assessed in two hundred subjects. Well structured questionnaires were used to assess smoking status,
duration of diabetes, age, weight, and height from the participants. Measurement of blood pressure was done to
ascertain the blood pressure of the subjects. Analysis of fasting blood sugar was done to confirm diabetes s tatus of
participants. Body mass index (BMI), was calculated from the height and weight. The mean age of males in the
study was higher than that of the females (P=.05). Mean SBP and DBP values were significantly higher (P=.05)
among the Ikwerres and Ogonis. BMI was significantly higher for Ogonis than Ikwerres ( P=.05). In the various
categories of risk, BMI for males was diabetics (47.89), smokers (44.73) and hypertensives (45.37) for type III
obesity which shows a higher risk for cardiovascular disease.
Dr Debbie Lowe - The future of innovation in AF and stroke preventionInnovation Agency
Presentation by Dr Debbie Lowe, Clinical Lead - Stroke, Getting It Right The First Time: Getting it right first time at The future of innovation in AF and stroke prevention in the NWC, 27 June 2018, Haydock Park Racecourse
A Study of the Prevalence of Cardio-Vascular Diseases and Its Risk Factors (B...inventionjournals
International Journal of Pharmaceutical Science Invention (IJPSI) is an international journal intended for professionals and researchers in all fields of Pahrmaceutical Science. IJPSI publishes research articles and reviews within the whole field Pharmacy and Pharmaceutical Science, new teaching methods, assessment, validation and the impact of new technologies and it will continue to provide information on the latest trends and developments in this ever-expanding subject. The publications of papers are selected through double peer reviewed to ensure originality, relevance, and readability. The articles published in our journal can be accessed online.
Non-communicalbe diseases and its preventionShoaib Kashem
Non communicable disease account for a large and increasing burden of disease worldwide. It is currently estimated that non communicable disease accounts for approximately 60% of global deaths and 43% of global disease burden. This is projected to increase to 73% of deaths and 60% of disease burden by 2020.
Class presentation at Pokhara University, MPH program
Point wise data on situation of cardiovascular disease focused on ischemic heart disease in Nepal.
Essential hypertension, the most common type, is an important cause of morbidity and mortality in the elderly, a rapidly growing section of the population. It is a sad reality that until the 1950s treating benign hypertension was not thought to be necessary. The tragic death of Franklin Delano Roosevelt on April 12, 1945 at the age of 63 years, with a blood pressure of 350/195mmHg, and without treatment shocked the healthcare community.
Hypertension is a silent, invisible killer that rarely causes symptoms. Increasing public awareness is key, as is access .Raised blood pressure is a warning sign that significant lifestyle changes are urgently needed. People need to know why raised blood pressure is dangerous, and how to take steps to control it.
The Future of Cardiology (2018 – 2030): Advanced Treatments to Combat the Global Advance of Cardiovascular Diseases. I presented this at Conference Series Cardiology Conference 2017 in Philadelphia, Pennsylvania on 09/01/2017. I first look the the number of people globally affected by cardiovascular diseases. Then I look at the cumulative "lost productivity" globally as a result of people suffering from cardiovascular diseases. Following that, I look at the total costs of treating cardiovascular diseases globally. Then I present the reasons why cardiovascular diseases are rising so rapidly throughout the world - lifestyle/clinical. Then I look at the rates of smoking throughout the world; one of the main culprits of cardiovascular diseases (CVDs). The next slides look at the "Gold Standard" of care for coronary artery diseases (CAD), congestive heart failure (CHF), and aortic valve disease. I also present what is driving industry consolidation and associated major transactions. I then provide some perspective on the future of interventional cardiology. And finally, I provide some insight into "evolving technologies" for cardiovascular care and interventional cardiovascular care. It was a lengthy presentation, but I feel, all critical. This is a very complex field. It takes at least 12 continuous years of education and training to become an interventional or non-interventional cardiologist (4 years pre-med, 3 years medical school, 3 years medical residency, 2 years fellowship (where a cardiologist selects and trains on their cardiovascular specialties)). Some authorities are even calling for post-fellowship training for procedures like transcatheter aortic valve implantation (TAVI) and pacemaker/ICD implantation.
Review ArticlePotential role of sugar (fructose) in the ep.docxronak56
Review Article
Potential role of sugar (fructose) in the epidemic of hypertension,
obesity and the metabolic syndrome, diabetes, kidney disease, and
cardiovascular disease1�3
Richard J Johnson, Mark S Segal, Yuri Sautin, Takahiko Nakagawa, Daniel I Feig, Duk-Hee Kang, Michael S Gersch,
Steven Benner, and Laura G Sánchez-Lozada
ABSTRACT
Currently, we are experiencing an epidemic of cardiorenal disease
characterized by increasing rates of obesity, hypertension, the met-
abolic syndrome, type 2 diabetes, and kidney disease. Whereas ex-
cessive caloric intake and physical inactivity are likely important
factors driving the obesity epidemic, it is important to consider
additional mechanisms. We revisit an old hypothesis that sugar,
particularly excessive fructose intake, has a critical role in the epi-
demic of cardiorenal disease. We also present evidence that the
unique ability of fructose to induce an increase in uric acid may be a
major mechanism by which fructose can cause cardiorenal disease.
Finally, we suggest that high intakes of fructose in African Ameri-
cans may explain their greater predisposition to develop cardiorenal
disease, and we provide a list of testable predictions to evaluate this
hypothesis. Am J Clin Nutr 2007;86:899 –906.
KEY WORDS Fructose, uric acid, sugar, arteriosclerosis, en-
dothelial dysfunction, hypertension, obesity, chronic kidney dis-
ease, metabolic syndrome
INTRODUCTION
Despite our best efforts, the epidemic of cardiorenal disease
continues to increase at an alarming rate. Obesity affects one-
third of adults and one-sixth of children in the United States and
continues to increase; although dietary interventions are often
initially successful, they often fail over time because of attrition
(1). Likewise, hypertension affects nearly one-third of the pop-
ulation, but despite the presence of effective antihypertensive
agents, nearly two-thirds of these patients remain either un-
treated or are treated ineffectively (2). Furthermore, even if the
hypertension is controlled, these subjects continue to have in-
creased cardiovascular mortality (3). Diabetes, a complication of
obesity, now affects 7% of our population, with approximately
one-third doomed to develop various complications such as ret-
inopathy or nephropathy (4). Kidney disease also continues to
increase at a deplorable rate, a consequence of the increasing
frequency of hypertension and diabetes (5). Today, nearly 20
million Americans have stage 1 kidney disease or greater (de-
fined as the presence of microalbuminuria or a glomerular fil-
tration rate �90 mL�min�1�1.73 m�2; 6), and, although treat-
ments such as angiotensin-converting enzyme inhibitors are
beneficial, they act primarily to delay the progression to renal
failure as opposed to halting the process (7).
It is our opinion that the potential mechanisms underlying the
epidemic should be carefully reappraised. On the basis of both
the experimental studies performed in our laboratorie ...
http://www.thinkred.co.za/get-involved/events | Thousands of people around the globe are affected by at least one type of Cardiovascular Disease (CVD) every day. This only emphasises the importance of heart health in this day and age. Learn what CVD is about the impact that it has had on people over the years. With simple diet and lifestyle changes many diagnosed individuals can overcome this threat.
Liz Rolfe's presentation Health Inequalities within an Ageing Population (SWO Seminar, Gloucestershire Local Intelligence Network).
Thursday 5th November 2009
Assessment of the Prevalence of Some Cardiovascular Risk Factors among the O...Scientific Review SR
The prevalence of some cardiovascular risk factors among the Ogonis and Ikwerres in Rivers State,
Nigeria was assessed in two hundred subjects. Well structured questionnaires were used to assess smoking status,
duration of diabetes, age, weight, and height from the participants. Measurement of blood pressure was done to
ascertain the blood pressure of the subjects. Analysis of fasting blood sugar was done to confirm diabetes s tatus of
participants. Body mass index (BMI), was calculated from the height and weight. The mean age of males in the
study was higher than that of the females (P=.05). Mean SBP and DBP values were significantly higher (P=.05)
among the Ikwerres and Ogonis. BMI was significantly higher for Ogonis than Ikwerres ( P=.05). In the various
categories of risk, BMI for males was diabetics (47.89), smokers (44.73) and hypertensives (45.37) for type III
obesity which shows a higher risk for cardiovascular disease.
Dr Debbie Lowe - The future of innovation in AF and stroke preventionInnovation Agency
Presentation by Dr Debbie Lowe, Clinical Lead - Stroke, Getting It Right The First Time: Getting it right first time at The future of innovation in AF and stroke prevention in the NWC, 27 June 2018, Haydock Park Racecourse
A Study of the Prevalence of Cardio-Vascular Diseases and Its Risk Factors (B...inventionjournals
International Journal of Pharmaceutical Science Invention (IJPSI) is an international journal intended for professionals and researchers in all fields of Pahrmaceutical Science. IJPSI publishes research articles and reviews within the whole field Pharmacy and Pharmaceutical Science, new teaching methods, assessment, validation and the impact of new technologies and it will continue to provide information on the latest trends and developments in this ever-expanding subject. The publications of papers are selected through double peer reviewed to ensure originality, relevance, and readability. The articles published in our journal can be accessed online.
Non-communicalbe diseases and its preventionShoaib Kashem
Non communicable disease account for a large and increasing burden of disease worldwide. It is currently estimated that non communicable disease accounts for approximately 60% of global deaths and 43% of global disease burden. This is projected to increase to 73% of deaths and 60% of disease burden by 2020.
Class presentation at Pokhara University, MPH program
Point wise data on situation of cardiovascular disease focused on ischemic heart disease in Nepal.
Essential hypertension, the most common type, is an important cause of morbidity and mortality in the elderly, a rapidly growing section of the population. It is a sad reality that until the 1950s treating benign hypertension was not thought to be necessary. The tragic death of Franklin Delano Roosevelt on April 12, 1945 at the age of 63 years, with a blood pressure of 350/195mmHg, and without treatment shocked the healthcare community.
Similar to Features of cardiovascular system activity in various climatic & geographical conditions (20)
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Features of cardiovascular system activity in various climatic & geographical conditions
1. Features of cardiovascular
system activity in various climatic
& geographical conditions
Anatomical & Physiological Aspects of Cardiovascular System
Sanskar Virmani, MM-206 (2022-2023)
School of Medicine, V. N. Karazin Kharkiv National University
Department of Human Anatomy and Physiology
3. European Origin
People of European origin include those who originate from diverse backgrounds in Northern Europe
(Nordic countries), Western Europe (eg, United Kingdom and France), Southern Europe (eg, Spain and
Italy), and Eastern Europe (eg, Poland and Ukraine).
Disease Burden
Differences in the Age-Standardized Mortality Rates (ASMR) vary widely between European populations.
Data from the World Health Organization (WHO) indicate that the cardiovascular disease mortality rate
is 6-fold higher among men and women in the Russian Federation compared with people in France. In
1996, the ASMR for coronary heart disease (CHD) among males in the Russian Federation was 390/100
000 compared with 60/100 000 among males in France.1 The cerebrovascular disease (CBVD) ASMR was
244/100 000 among males in the Russian Federation compared with 40/100 000 in France.1 Although the
CVD mortality rates are much lower among women compared with men, similar variations among
women between countries also exist. Eastern European countries such as the Ukraine, the Russian
Federation, Hungary, and the Czech Republic have among the highest and increasing CVD rates in the
world, which is in marked contrast to most economically stable European countries where declines in
CVD mortality rates have been experienced over the past 30 years
4. European Origin (Contd.)
Risk Factors
CVD among European populations is mainly attributable to classical risk factors, namely diets high in
saturated fats, elevated serum cholesterol and blood pressure (BP), diabetes, and smoking. The
epidemic of CVD in Eastern European countries is partly related to high levels of smoking and excessive
alcohol use (causing strokes) along with diets high in saturated fat and poor social conditions.
Research to explain why the Italian and French populations remain relatively protected from CHD has
yielded numerous hypotheses. It is believed that the high consumption of monounsaturated fats such
as olive oil and antioxidants may be responsible for the low rates of CHD in Italy. In France, the CHD
mortality rate remains very low. Although this relative protection from CHD has been attributed to high
consumption of alcohol, and in particular wine, others believe the lower rate of CHD mortality may
simply be due to a time-lag between increases in consumption of animal fat and elevations in serum
cholesterol concentrations (which have occurred only recently) and the expected increase in mortality.
5. Japanese Origin
Disease Burden
In parallel with a rise in economic prosperity, CVD rates in Japan have declined more markedly than those
of western countries, and the life expectancy in Japan is among the highest in the world. Mortality rates
from CHD have traditionally been much lower in Japan than in western countries. In Japan, the ASMR for
CHD in males is 43/100 000 and in females is 22/100 000, which is one-fourth the rate of CHD in North
America, and for CBVD is 72/100 000 and 46/100 000 among males and females, respectively. This pattern
of higher CBVD compared with CHD among Japanese differs from western populations.
Risk Factors
Hypertension is the most important CVD risk factor among Japanese, more so than cholesterol and
cigarette smoking. The Hisayama prospective population–based study showed a decline in BP level from
1961 to 1987,13 likely due to improved diagnosis and treatment of hypertension. This has been accompanied
by a marked decline in stroke mortality. Low serum cholesterol related to a diet low in saturated fat and
cholesterol is also likely responsible for the low rates of CHD mortality observed in the Japanese. The
prevalence of non–insulin dependent diabetes mellitus (NIDDM) in Japanese males (13%) and females (9%)
is higher than the rates in most western countries. During 1961 to 1987, with westernisation there was a 2-
to 3-fold increase in glucose intolerance, NIDDM, obesity, and hypercholesterolemia (the mean cholesterol
is only 10% lower than in the US in 1989). It is possible that as cholesterol and glucose levels rise, the
impact of the high cigarette smoking on increased CVD rates may become manifest.
6. Disease Burden
Death rates from CVD (particularly CHD) have been increasing in China in recent decades.16 Although the
CVD mortality rate in China is approximately the same as that in the US, the CHD mortality rates are
approximately 50% lower than the rates observed in most western countries, and the CBVD rate is
significantly higher. In 1996, in urban China, the ASMR for CHD for men and women aged 35 to 74 was
100/100 000 in men and was 69/100 000 in women.17 However, the ASMR for CBVD in men and women aged
35 to 74 was 251/100 00 in men and 170/100 000 in women.17 Intracerebral hemorrhage occurs between 2
and 3 times more frequently in the Chinese than in white Caucasians. Only 6% to 12% of strokes in
European populations are reported as intracerebral hemorrhages compared with 25% to 30% of
hemorrhagic strokes in Chinese.
Risk Factors
A case-control study from Hong Kong of acute myocardial infarction (AMI) sufferers indicates that
conventional risk factors (eg, cigarette smoking, hypertension, or diabetes) are important. Although the
mean serum cholesterol among Chinese is low (mean 4.2 mmol/L at baseline) by western standards,
serum cholesterol was directly related (continuous relationship) to CHD mortality even at relatively low
levels.Cigarette smoking is highly prevalent among Chinese males (over 60%) and increasing.
Chinese Origin
7. Chinese Origin (Contd.)
Geographic Variations
The CHD mortality rate is higher in northern China (Beijing) than in southern China (Shanghai and
Guangzhou) and higher in urban than rural areas, yet surprisingly the stroke rates only differ modestly
between urban and rural areas. The prevalence of hypertension, mean levels of serum cholesterol, and body
mass index (BMI) were all lower in the south compared with the north and in rural compared with urban
areas.
Figure 1. Variations in the rates of cardiovascular disease (CHD)
between ethnic groups in Canada.25 Note the high rates of CHD
among Canadians of European and South Asian descent
compared with the markedly low rates among Chinese. The rates
of cerebrovascular disease are low and similar in all 3 ethnic
groups. By contrast, cancer death rates are lowest among South
Asians and highest among Europeans, with Chinese exhibiting
intermediate rates. This apparent dissociation of CHD and cancer
rates is surprising because several of the common causes of
heart disease and common cancers tend to be the same (eg,
tobacco use or obesity).
8. Disease Burden
There are relatively few mortality studies from India, as there is no uniform completion of death
certificates and no centralized death registry for CVD. However, the WHO and the World Bank estimate
that deaths attributable to CVD have increased in parallel with the expanding population in India, and
that CVD now accounts for a large proportion of disability adjusted life years (DALY) lost. Of all deaths in
1990, approximately 25% were attributable to CVD, compared with 10% from diarrheal diseases, 13% from
respiratory infections, and 8% from tuberculosis. SA migrants to the United Kingdom, South Africa,
Singapore, and North America experience 1.5 to 4.0 times higher CHD mortality compared with
indigenous populations).
South Asian Origin
South Asian (SA) refers to people who originate from India, Sri Lanka, Bangladesh, Nepal, and Pakistan.
9. South Asian Origin (Contd.)
Risk Factors
Compared with Europeans, SAs (in the UK and Canada) do not display high rates of smoking,
hypertension, or elevated cholesterol but still have higher rates of CHD. However, smoking, hypertension,
and diabetes are strongly associated with CHD among SAs. SAs in the UK and Canada suffer a high
prevalence of impaired glucose tolerance (IGT), central obesity, elevated triglycerides, and low HDL
cholesterol, and NIDDM at rates 4 to 5 times higher than in Europeans (19% versus 4% by age 55
years).33,35 High rates of diabetes has been reported among SAs in the UK (10% to 19%), Trinidad (21%),
Fiji (25%), South Africa (22%), Mauritius (20%), and Canada (10%). By contrast, the prevalence of diabetes
in rural India is 2% to 3% and approximately 8% in urban areas. In addition, there is increasing evidence
that elevations in blood glucose even in the nondiabetic range increases CHD risk among SAs. SAs have
elevated levels of Lp(a), a lipoprotein which is genetically mediated and associated with increased
atherosclerosis, thrombogenesis, and clinical events. Recent studies have confirmed that SAs also have
higher levels of homocysteine, fibrinogen, and plasminogen activator inhibitor (PAI-1), all of which could
increase the risk for thrombosis. Although the degree of subclinical atherosclerosis is related to clinical
events, it appears that SAs have a higher propensity for clinical events compared with Europeans or
Chinese, even after adjusting for all known risk factors and the degree of atherosclerosis (Figure 2). This
probably suggests the potential for greater plaque rupture and thrombotic events among SAs.
10. South Asian Origin (Contd.)
Geographic Variations
Marked increases in both CHD prevalence and risk factors is observed in urban India compared with
rural settings. A recent overview of prevalence surveys conducted over 2 decades in India reported a 9-
fold increase of CHD in urban centers, compared with a 2-fold increase in CHD rates among rural
populations. This increase in CHD rates in urban areas is associated with an increase in the prevalence
of lipid and glucose abnormalities as well as hypertension and obesity. By contrast, the rates of tobacco
smoking are higher in rural compared with urban populations. (Although these studies used somewhat
different methods of sampling and varying definitions for CHD, collectively, they suggest that there is
likely a real increase in CHD; however, the magnitude of the increase remains uncertain).
Figure 2. Prevalence of CVD for specific degrees of carotid
atherosclerosis. Note that the prevalence of CVD increases
with increasing carotid atherosclerosis in each ethnic group.
However, it appears that South Asians (SA) have more CVD
compared with Chinese (CH) and Europeans (EU) for the
same degree of atherosclerosis.
11. Disease Burden
CVD is the leading cause of death among Hispanic males (28%) and females (34%). Although earlier
studies suggested that the age-adjusted mortality rates for major CVD among Mexican-Americans (28.8
and 26.6 per 100 000 men and women, respectively) were lower than those of African-Americans (40.5
and 39.6, respectively) and whites (30.0 and 23.8 per 100 000),42 recent data from the Corpus Christi
Heart Project, reported a greater incidence of myocardial infarction (MI) in Mexican-Americans
compared with non-Hispanic whites.43 The age-adjusted MI incidence was higher by 1.25 and 1.52
among Mexican-American men and women compared with non-Hispanic whites, with greater MI case-
fatality rate among Mexican-Americans than non-Hispanic whites.
Under the age of 60 years, Hispanics have a significantly elevated CBVD death rate compared with non-
Hispanic whites (32 versus 19 and 23 versus 18 per 100 000 in men and women, respectively). However,
in older age categories the CBVD rate in Hispanics is substantially lower than whites (589 versus 765
and 535 versus 847, respectively). Although declines in CHD and CBVD mortality have occurred in
Mexican-Americans over the past 20 years, this decline has been less than that which has occurred
among non-Hispanic whites.
Hispanic Origin
The term Hispanic includes Americans of Cuban, Mexican, and Puerto Rican descent. There are
approximately 35.3 million Mexican-Americans living in the US, and they comprise approximately 12.5%
of the US population.
12. Hispanic Origin (Contd.)
Risk Factors
Mexican Americans suffer a high
prevalence of conventional CVD
risk factors such as smoking
(42.5% in men and 23.8% in
women), hypertension (17% and
14%, respectively), low HDL
cholesterol (<0.90 mmol/L: 15.2%
men, 5% women), elevated
cholesterol (total cholesterol ≥6.2
mmol/L: 16.6% men and 16.5%
women), diabetes (24%), physical
inactivity (39%), and obesity
(BMI>85th percentile, 30% men,
39% women)
13. Disease Burden
Mortality rates for CVD among aboriginal populations had been reported to be lower than people of
European ancestry; however, CHD is the leading cause of death in North American Indians and Alaskan
Natives.41 The Strong Heart Study, which was initiated in 1988, studied 4549 American Natives aged 45
to 74 years from 13 tribes in the Southern US. The prevalence estimates of definite MI in those aged 45 to
74 years was 2.8% in men without diabetes and 5.3% in men with diabetes, and 0.4% in women without
diabetes and 1.4% in women with diabetes. In the US, the CBVD mortality rates under the age of 65 years
is similar in Native Americans and white Americans, and substantially lower than rates in African
Americans.
In Canada, CVD is the leading cause of death among Aboriginal peoples. Although the CHD mortality
rates among Aboriginal and Canadian males are similar, the CHD mortality among Aboriginal women is
61% higher compared with Canadian women. In addition, the stroke mortality rate is 44% and 93% higher
among Aboriginal men and women, respectively, compared with the general Canadian population.
However, all the above data are based on studies conducted 10 or more years ago. A recent prevalence
study in Canada indicates a 2.5-fold higher rate of CVD among aboriginal peoples compared with
Canadians of European origin.
Aboriginal Populations
The rates of chronic degenerative diseases such as CVD, diabetes, cancer, and mental illness are
increasing among Aboriginal peoples. These trends parallel the epidemiological transition that is
occurring in other developing populations throughout the world.
14. Aboriginal Populations (Contd.)
Risk Factors
The common CHD risk factors among Aboriginal men and women include diabetes, obesity, and low HDL-
cholesterol. The prevalence of cigarette smoking is high, with wide variations between reserves. The
prevalence of diabetes in the Strong Heart Study was 48% in the group aged 45 to 64 years compared with
approximately 5.5% in the US general population. The prevalence of obesity ranged from 26% to 41%, with an
average BMI of 31 and waist-hip ratio of 0.97 in men. By contrast, the prevalence of hypertension and
elevated cholesterol among Natives appears to be lower than the general US population.
In a Canadian study, Aboriginal people had a higher prevalence of CVD, atherosclerosis, glucose
abnormalities, obesity, and poverty compared with European Canadians. There is a clear inverse
relationship between higher incomes and lower rates of risk factors and CVD. However, at each income
level, aboriginals had higher risk factors and CVD compared with European Canadians.
Geographic Variations
There are important regional and inter tribal differences in CVD risk factors and disease rates, but most of
the current data on CVD have come from Natives living on reserves, and little is known about the risk factor
profiles among city-dwelling Natives. There are only very limited data regarding CVD among Aboriginal
populations outside North America. One study in Chile, among the Mapuche Indians indicated
substantially lower rates of obesity, diabetes, hypertension, or hyperlipidemia compared with the North
American Aboriginal populations
15. General
Prevention
Strategies
Schema for societal level “Pathway” for the development of atherothrombotic cardiovascular diseases.
*The contrasting lifestyles between urban and rural settings are typical for countries in early and mid
transition. However, in late transition countries, lifestyles in rural settings have been altered due to
mechanization and various social influences so that they are similar to urban settings. Consumption of
inappropriate diets, higher rates of tobacco use, and decreases in physical activity even in rural
settings increase risk factors and lead to higher CVD rates. These changes are already evident in North
America. Risk factors probably play a role from the intrauterine period, through childhood to adulthood.
16. General
Prevention
Strategies
An integrated population-based and high risk individualized strategy for the prevention of CVD. The
arrows represent the interactive nature of the various strategies. For example, in a community that has
a tobacco control policy, it is easier for an individual subject to quit smoking. Conversely, encouraging a
patient with clinical coronary artery disease to quit smoking may promote appropriate changes among
family members and coworkers. This in turn may encourage children to adopt healthy lifestyles.
18. Climate change has led to more frequent
extreme temperatures in many areas,
increasing the likelihood of cardiovascular
events. Factors such as air pollution, age,
and socioeconomic and health status must be
taken into account to prevent and combat
cardiovascular illnesses.
19. Cardiovascular risks
of climate change
❏ Climate change is causing global warming, evidenced by a 1°C rise in global average surface
temperature. This has caused greater temperature variability and frequent extreme heat
events, such as the 2003 heatwave in Central Europe which led to 70,000 deaths. Exposure
to extreme heat has increased globally, with an extra 220 million exposure events in 2018
compared to the pre-industrial average.
❏ Both low and high temperatures are linked to cardiovascular mortality, but the magnitude of
the risk is influenced by culture and climate. Over 1.96 million deaths due to non-optimal
temperatures were calculated globally during 2015, with a larger burden from cold than from
heat. In Germany, the risk of myocardial infarction increased from cold to warm
temperatures during 2001-2014, and those with type 2 diabetes or hypertension were more
vulnerable to the change. These health risks are already present and will worsen with
uncontrolled climate change.
20. Cardiovascular risks of
climate change (Contd.)
❏ An increase in temperatures is associated with an increased risk of acute-onset ischaemic
heart disease. This is linked to disruptions of haemostasis which can lead to atherosclerotic
plaque rupture and potential myocardial infarctions. Individuals with heart failure are
particularly at risk of being unable to compensate for the increased circulatory demand of
the heat. The joint effect of exposure to heat and air pollution has been linked to
cardiovascular disease mortality. Studies have shown that mortality due to heat is three
times higher with high concentrations of particulate matter compared to low
concentrations.
❏ The data suggest that urgent action is required to address climate change and reduce air
pollution. Investing in eco-friendly public transport and promoting active modes of
transportation like biking and walking may be beneficial. Political changes must be made in
order to protect future generations from cardiovascular diseases. Moreover, those already
suffering from cardiovascular diseases must take preventive measures. Further research is
needed to understand how activities such as wearing wearable devices or diagnosing
glycaemia can be used to treat cardiovascular diseases. During the current Covid-19
pandemic, exposure to both heat and cold can increase the risk of mortality.
21. ❏ Climate change increases the risk of cardiovascular disease events and is expected to result
in increased heat-related deaths in the coming decades. Policy measures must be taken
urgently to achieve the Paris Agreement and reduce avoidable acute cardiovascular disease
events.
Cardiovascular risks of
climate change (Contd.)
Factors contributing to the cardiovascular risks of climate change.
Extreme heat events are becoming more frequent due to global warming and the associated health
risks are aggravated by air pollution. Those particularly vulnerable are the elderly, those from low
socioeconomic status and those with certain pre-existing conditions like diabetes and hypertension,
which can lead to cardiovascular disorders such as heart attack.
22. Climate change is anticipated to have a long-term impact on human health, with increases in
temperature potentially leading to weather-related morbidity and mortality, largely due to
cardiovascular and respiratory events. According to the World Health Organization (WHO), 150,000
deaths associated with 5 million “disability-adjusted life years” have been linked to climate
change in the last three decades. Studies have identified differences in population demographics,
location, local climate, study design, and statistical methodology and have revealed detrimental
effects of both hot and cold weather on the risk of myocardial infarction.
Environmental effects on cardiovascular physiology and pathological states can be triggered by
extremely high or low temperatures, particularly for the elderly. It has been suggested that many
climate-change related deaths occurred before patients could be taken to hospital. measures to
reduce such mortality must be performed in advance of climate change arriving, yet insufficient
funding has been made available by the U.S. government to combat existing health problems.
Particularly, “Hot & Cold”...
23. Extreme heat temperature on human
cardiovascular diseases
Research has found that cardiovascular diseases are
the main cause of deaths caused by high
temperatures. 98 papers dating from 1957 to 2002,
found that a 3% increase in death rates per 1°C increase
in temperature occurs in hot regions, with a 2.6%
increase in cardiovascular mortality in North America
for a 10°F increase. It has also been found that high
temperature increases platelet and red cell count and
can lead to coronary and cerebral diseases.
Additionally, high relative humidity has been linked to
increased mortality due to acute myocardial infarction.
Finally, age-related differences in cutaneous
vasodilation have been linked to difference in skin
temperature, with functional nitric oxide being required
for full expression of cutaneous vasodilation.
24. Extreme cold temperature on human
cardiovascular diseases
Exposure to cold weather has been associated with an
increase in heart rate, blood pressure,
vasoconstriction, and cardiac mortality. Studies in the
Czech Republic and other parts of Europe observed a
positive correlation between cold spells and mean
excess cardiovascular mortality, in both men and
women of all ages. This, along with reports of
increased cardiovascular abnormalities and cardiac
death during winter months, indicates a significant
public health threat posed by cold weather. Facial
cooling has been found to increase wave reflection
and augmentation of systolic pressure, further leading
to potential ischemia and mortality. Lag periods
between a cold spell and its effects on mortality are
usually longer, and the geographic variability is
greater, than those of heat waves.
25. Mechanisms of heat temperature on
cardiovascular diseases
Extreme climatic changes have been linked to higher daily
mortality levels around the world. Clinical trials have
shown that exposure to hot temperatures can increase
blood viscosity and cholesterol levels and might lead to
coronary artery illness, cerebral infarction, thromboembolic
diseases, and malignant cardiac arrhythmias. Additionally,
high temperatures can induce changes such as increased
cardiac output and dehydration. Balloux et al's results
suggest that population genetics and climate are related,
and that further study of the relationship between genetic
polymorphisms due to climatic stress and cardiovascular
diseases is needed.
26. Mechanisms of cold temperature on
cardiovascular diseases
Exposure to cold weather has been associated with morbidity and
mortality from cardiovascular illness, including sudden death.
Atherosclerotic coronary arteries constrict in response to cold-
related sympathetic outflow and this can cause an imbalance in
oxygen supply to myocardium. Cold-induced systemic vascular
resistance and increased blood pressure can wreak havoc on
hypertensive patients. Multiple physiologic functions are impacted
by cold weather, including elevated blood pressure, increased
sympathetic activity, and platelet aggregation. Erythrocyte count,
plasma cholesterol and fibrinogen levels surge in cold weather,
thus increasing the risk of arterial thrombosis. Adrenergic α2C
activity is raised in cutaneous tissue in response to cold, and this
is translated to deeper vessels with estrogen enhancement.
Inhibition of sympathetic activity reduces the cutaneous
vasoconstrictor response to cold.
27. Inference
A ten-year study in Great Britain showed that deaths from coronary heart
disease were significantly increased in winter. Influenza vaccinations were
found to be associated with a 50% reduction in incidence of cardiovascular
abnormality and sudden cardiac death. Models of weather-mortality were
developed to potentially project the consequences of climate-change
scenarios, although the effect of extreme climatic change on cardiovascular
disease is difficult to predict. It is suggested that cold stress should be
considered a potential risk factor of sudden cardiovascular events, and there
is an urgent need for studies to explore the risk factors and develop preventive
strategies.
28. Features of cardiovascular system activity in various
climatic & geographical conditions
Anatomical & Physiological Aspects of Cardiovascular System
Sanskar Virmani, MM-206 (2022-2023)